Skip to Content

Cardura XL Pfizer Inc. - Treatment for Benign Prostatic Hyperplasia (BPH)

Cardura XL is an extended release formulation providing a controlled release of doxazosin over a 24-hour period. Cardura XL is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). Cardura XL is not indicated for the treatment of hypertension.

Posted: February 2005

Cardura XL (doxazosin mesylate) FDA Approval History